SCHEMBL6990788

SCHEMBL6990788

COc1ccc(-c2cccs2)cc1C(=O)C=C(C(=Cc1cc(OC)c(OC)c(OC)c1)C(=O)c1cc(-c2cc3ccccc3s2)ccc1OC)c1ccc(Cl)c(Cl)c1O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 17/20 0.45
ERN1 O75460 1/20 0.37
ACLY P53396 1/20 0.36
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34
TUBA1C Q9BQE3 1/20 0.34
TUBB6 Q9BUF5 1/20 0.34
TUBB2B Q9BVA1 1/20 0.34
TUBB1 Q9H4B7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090845 0.83 TNFRSF1A (0.49) TNFRSF1AERN1ACLYTUBB4ATUBB
SCHEMBL5576279 0.68 TNFRSF1A (0.69) TNFRSF1A
SCHEMBL5571783 0.67 TNFRSF1A (0.68) TNFRSF1A
SCHEMBL5571785 0.67 TNFRSF1A (0.68) TNFRSF1A
SCHEMBL5576248 0.67 TNFRSF1A (0.67) TNFRSF1A
SCHEMBL5576247 0.67 TNFRSF1A (0.67) TNFRSF1A
SCHEMBL5576254 0.67 TNFRSF1A (0.67) TNFRSF1A
SCHEMBL7060125 0.65 TNFRSF1A (0.46) TNFRSF1ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5574936 0.63 TNFRSF1A (1.00) TNFRSF1A
SCHEMBL5574934 0.63 TNFRSF1A (1.00) TNFRSF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1330448-A2 1,3-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND THEIR USE TO TREAT VCAM-1 MEDIATED DISORDERS Atherogenics, Inc. (US) 2003-07-30 EP claimed
WO-2001098291-A2 1,3-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND THEIR USE TO TREAT VCAM-1 MEDIATED DISORDERS ATHEROGENICS, INC. (US) 2001-12-27 WO claimed